Image: Researchers from our Centre for Protein DegradationThe Institute of Cancer Research and biotechnology company NEOsphere Biotechnologies have announced a...
Skyhawk Therapeutics enters into an option agreement to grant Merck KGaA, Darmstadt, Germany, exclusive global rights to drug candidates pursued...
Skyhawk Therapeutics Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders Skyhawk...
Biogen And Neomorph Announce Multi-Target Research Collaboration To Discover And Develop Molecular Glue Degraders For Alzheimer’S, Rare, And Immunological...
TRIANA will receive an upfront payment of $49 million, and is eligible to receive future milestone payments and royalties LEXINGTON,...
BeyondSpring, Inc.SEED Concurrently Enters into Share Purchase Agreements for its Series A-3 Financing Led by EisaiThe SEED-Eisai Research Collaboration leverages...
